The SCN2A gene helps brain cells send the electrical signals needed for learning, speech, movement, and behavior. When it does not work properly, brain signaling can become too active or not active enough. People with a pathogenic variant in the SCN2A gene may have seizures, developmental delay, features of autism, intellectual disability, or movement problems. The exact pattern can differ a lot from one person to another because different variants affect the gene in different ways.
What is a gene?
A gene is a piece of DNA that carries instructions cells can use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do the work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. More detailed information about this topic is available in the LearnHub.
Overview
SCN2AGene function
What if the gene works
The SCN2A gene helps brain nerve cells make a sodium channel, a protein that carries electrical signals. This supports normal communication between brain cells, especially during early brain development.
Risk
What if the gene does not work
Variants in the SCN2A gene can lead to epilepsy, developmental delay, autism, or movement problems. Milder and severe variants may change how nerve cells send signals, influencing when symptoms begin, how severe they are, and which features appear.
Treatment
What does that mean for your treatment
For loss-of-function variants in the SCN2A gene, no established gene-specific treatment is currently part of care. In SCN2A-related epilepsy, medicines that block sodium channels can help mainly when a variant increases channel activity, so they are not a standard choice for loss-of-function variants. Treatments designed to raise SCN2A activity are under study.
Conditions associated with SCN2A
Gene function
What if the gene works
In the brain, the SCN2A gene helps nerve cells send fast electrical messages. It provides instructions for part of a sodium channel, a tiny gate in the cell membrane that opens and closes in milliseconds. Understanding SCN2A gene function helps explain how brain cells communicate smoothly during everyday activity.
The SCN2A gene provides instructions for part of a channel that lets sodium enter nerve cells. This brief sodium flow helps create the electrical change a brain cell uses to send a message.
Many brain cells place this channel where an electrical signal begins. Its quick opening helps start an action potential (the nerve cell's electrical signal) at the right moment.
This channel also helps electrical signals move along parts of the nerve cell after they begin. That keeps communication between brain cells fast and coordinated.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal differences among people, including appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the SCN2A gene, different DNA changes can alter how the Nav1.2 sodium channel works, which helps explain how SCN2A gene variants affect nerve cell signaling. Some variants make the channel open too easily or stay active longer, increasing sodium flow, while others reduce channel activity, stability, or delivery to the nerve cell surface. Milder changes may lower function a little, but more severe variants can leave little or no channel and may be linked to earlier or marked symptoms.
How variants are linked to conditions
Pathogenic variants in the SCN2A gene can cause a spectrum of neurologic conditions, most often early-onset epilepsy, developmental delay, intellectual disability, and autism spectrum disorder. Some people mainly have seizures, while others have learning and behavior differences with few or no seizures. This includes SCN2A gene variants linked to epilepsy and autism spectrum disorder, ranging from self-limited infant seizures to developmental and epileptic encephalopathy.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found across the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SCN2A-related conditions, risk is mostly linked to the specific change in the SCN2A gene itself and whether that change is inherited or happens new in a child. There is not yet broadly confirmed evidence that lifestyle or everyday environmental factors meaningfully change the chance of developing an SCN2A-related condition.
Inheritance of SCN2A variants
For most SCN2A-related conditions, the SCN2A inheritance pattern is autosomal dominant, which means a child can be affected if they inherit one altered copy of the SCN2A gene. If a parent carries a disease-causing variant in the SCN2A gene, each pregnancy has a 50% chance of passing it on. Some people with an SCN2A-related condition have a new, de novo variant that was not inherited from either parent.
What does my SCN2A result mean for my family?
SCN2A-related conditions are usually passed on in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change and may want to discuss whether testing is relevant for them. In many families, the change is new in the child and not found in either parent, so a parent is not always the source. The meaning for relatives can vary because SCN2A changes can be linked to different kinds of brain and development conditions.
Genetic information
Genetic testing
How you find out about variants
SCN2A genetic testing looks for variants in the SCN2A gene using a blood or saliva sample. A lab reads the gene’s DNA code to check for changes that may help explain seizures, developmental differences, or related findings. Results may show a variant linked to the condition, a harmless variant, or an uncertain result.
When should I consider getting a genetic test?
Testing for the SCN2A gene may be worth considering if a child has seizures that start very early, repeated unexplained seizures, or developmental delays with autism or learning problems. It can also help when there is a family history of similar symptoms or when doctors are looking for the cause of a seizure-related condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. That helps explain why the same medication may work well for one person, seem less helpful for another, or cause more side effects in someone else. These differences are common and are one part of the larger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes affect the way people respond to medications. It studies the connection between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the SCN2A gene
When should I seek medical advice?
There is not yet a broadly confirmed medication-response role for this gene, so general concerns about symptoms or medicines are best discussed with your doctor. SCN2A has been studied in epilepsy care, where some gene changes may affect how well certain anti-seizure medicines that block sodium channels work, so it is worth bringing up if seizures are hard to control or treatment plans are changing.
History
SCN2A entered medical genetics through research on inherited seizure conditions in the 1990s, when scientists began linking changes in this gene to epilepsy in some families. From these first observations, research expanded steadily. In the early 2000s, SCN2A was recognized as a cause of benign familial neonatal infantile seizures, which helped clarify why some babies had seizures soon after birth. As genetic testing became more widely used, doctors and researchers also connected SCN2A variants with a broader range of childhood brain and development conditions, including developmental delay and autism. This shift turned SCN2A from a gene tied mainly to epilepsy into one understood as part of a wider neurodevelopmental picture.